Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia

Autor: J. Crezee, A. Bakker, R. Zweije, M. W. Kolff, H. J. G. D. van den Bongard, G. van Tienhoven, H. P. Kok

Publikováno v: Crezee, J, Bakker, A, Zweije, R, Kolff, M W, van den Bongard, H J G D, van Tienhoven, G & Kok, H P 2022, Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia . in Water-filtered Infrared A (wIRA) Irradiation: From Research to Clinical Settings . Water-filtered Infrared A (wIRA) Irradiation: From Research to Clinical Settings, Springer International Publishing, pp. 97-106 . https://doi.org/10.1007/978-3-030-92880-3_7
Water-filtered Infrared A (wIRA) Irradiation ISBN: 9783030928797

Clinical hyperthermia (i.e., heating of tumor tissue to 40–43 °C) is used in clinical oncology to enhance the therapeutic effect of chemotherapy and radiotherapy. Most recurrent breast cancer and melanoma lesions reach up to a few cm deep and can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::253d49563e37c8d8109c615a0bbba309
https://research.vumc.nl/en/publications/7fdf70ab-a89f-4df7-b098-3061677bb496

Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction

Autor: F C J, Reinders, D A, Young-Afat, M C T, Batenburg, S E, Bruekers, E A, van Amerongen, J F M, Macaré van Maurik, A, Braakenburg, E, Zonnevylle, M, Hoefkens, T, Teunis, H M, Verkooijen, H J G D, van den Bongard, W, Maarse

Publikováno v: Breast cancer (Tokyo, Japan). 27(3)

To improve shared decision making, clinical- and patient-reported outcomes between immediate implant-based and autologous breast reconstruction followed by postmastectomy radiotherapy (PMRT) were compared.All women with in situ and/or invasive breast

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59abd603d5adfee8c15eeffe2ad863c0
https://pubmed.ncbi.nlm.nih.gov/31858435

In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood

Autor: J. H. M. Schellens, R. C. A. M. Van Waardenburg, M. Ravic, J. H. Beijnen, Dick Pluim, H. J. G. D. Van Den Bongard

Publikováno v: Anti-cancer drugs, 14(6), 405-410. Lippincott Williams and Wilkins

E7070 is a novel sulfonamide anticancer agent that arrests the G1/S phase of the cell cycle. Preclinical and phase I studies have demonstrated non-linear pharmacokinetics (PK) of the drug. A population PK analysis revealed that the human plasma conce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52759e1ae797e4b76bbcc6892d912c4
https://doi.org/10.1097/00001813-200307000-00003

Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry

Autor: Gianni Sava, Jan H.M. Schellens, O. van Tellingen, Jos H. Beijnen, M. Crul, Matthijs M. Tibben, H. J. G. D. Van Den Bongard

Publikováno v: Fresenius' journal of analytical chemistry. 369(5)

NAMI-A is a novel ruthenium-containing experimental anticancer agent. We have developed and validated a rapid and sensitive analytical method to determine NAMI-A in human plasma, plasma ultrafiltrate and urine using atomic absorption spectrometry wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ad4215cf2898397923b3f66a7d4d01
https://pubmed.ncbi.nlm.nih.gov/11270226

In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood.

Autor: H. J. G. D. van den Bongard

Publikováno v: Anti-Cancer Drugs; Jul2003, Vol. 14 Issue 6, p405, 6p